Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN Exclusives

More »

For full access to this article login to GEN Select now.

March 27, 2014

The Promise of Combination Therapies

Recent technical advances, new business strategies, and FDA policies will speed combination therapy development.

The Promise of Combination Therapies

Combination therapies frequently target proteins in different pathways involved in cell proliferation and disease spread in the body. [© JJAVA - Fotolia.com]

A number of diseases are complex multigene or multifactor diseases Some major ones are cancer, neuropsychiatric conditions such as schizophrenia and depression, obesity, and bacterial infections All these diseases extract a heavy financial toll on society For instance, neoplasms (cancer and related abnormal cell growth) cost $217 billion per year ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.

Related content